AZ showcases data for next-generation PARP inhibitor AZD5305

AZ showcases data for next-generation PARP inhibitor AZD5305

Source: 
PM Live
snippet: 

AstraZeneca (AZ) has unveiled early data for its next-generation PARP1 selective inhibitor AZD5305 – a potential successor to its blockbuster PARP treatment Lynparza.